{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-23-030356","form_type":"8-K","ticker":"IMDX","cik":"0001642380","company_name":"Insight Molecular Diagnostics Inc.","filed_at":"2023-08-28T23:59:59+00:00","discovered_at":"2026-05-14T18:03:34.657755+00:00","generated_at":"2026-06-11T02:54:12.833400+00:00","sec_items":["8.01","9.01"],"event_type":"regulatory","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Oncocyte's VitaGraft Kidney test receives Medicare coverage decision from Palmetto GBA","bullets":["Palmetto GBA, a Medicare Administrative Contractor, issued final LCD for VitaGraft Kidney test.","Test meets coverage criteria under MolDX: Molecular Testing for Solid Organ Allograft Rejection (L38568).","Decision could enable Medicare reimbursement for Oncocyte's transplant rejection test.","Coverage applies to beneficiaries under Palmetto GBA's jurisdiction.","Oncocyte announced the decision in an August 28, 2023 press release."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-23-030356","json":"https://secwatch.observer/filing/0001493152-23-030356.json","markdown":"https://secwatch.observer/filing/0001493152-23-030356.md","text":"https://secwatch.observer/filing/0001493152-23-030356.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1642380/000149315223030356/0001493152-23-030356-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1642380/000149315223030356/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-11T02:54:12.833400+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}